TSX-V:PHA - TSX Venture Exchange - CA74052G1063 - Common Stock - Currency: CAD
TSX-V:PHA (2/20/2025, 7:00:00 PM)
0.18
+0.01 (+2.86%)
The current stock price of PHA.CA is 0.18 CAD. In the past month the price increased by 20%. In the past year, price decreased by -71.43%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
WELL-DB.CA | WELL HEALTH TECHNOLOGIES | 837.5 | 25.12B | ||
AND.CA | ANDLAUER HEALTHCARE GROUP IN | 28.73 | 1.78B | ||
WELL.CA | WELL HEALTH TECHNOLOGIES COR | 51 | 1.53B | ||
DNTL.CA | DENTALCORP HOLDINGS LTD | 28.78 | 1.46B | ||
AIDX.CA | HEALWELL AI INC | N/A | 260.00M | ||
QIPT.CA | QUIPT HOME MEDICAL CORP | N/A | 151.88M | ||
KDA.CA | KDA GROUP INC | N/A | 54.49M | ||
NLH.CA | NOVA LEAP HEALTH CORP | N/A | 22.70M | ||
ARC.CA | ARCPOINT INC | N/A | 11.81M | ||
NPTH.CA | NEUPATH HEALTH INC | N/A | 11.24M | ||
JNH.CA | JACK NATHAN MEDICAL CORP | N/A | 2.18M |
Premier Health of America, Inc. engages in the provision of staffing and outsourced service solutions for healthcare needs. The company is headquartered in Blainville, Quebec and currently employs 555 full-time employees. The company went IPO on 2018-12-24. The firm provides a comprehensive range of outsourced service solutions for healthcare needs to governments, corporations, and individuals. The firm uses its proprietary LiPHe platform to lead the healthcare services sector in digital transformation to provide patients with more accessible care services. The firm operates through two segments: Per Diem and Travel Nurses. The Per Diem segment includes Premier Soin and Code Bleu, two of its Quebec subsidiaries that offer their respective services for nursing and assistance by profile and by region. The Travel nurse segment includes Canadian Health Care Agency, Premier Soin Nordik, Solutions Nursing as well as Solutions Staffing, four of its subsidiaries that offer their respective services to the federal and provincial governments for nursing and assistance, including in remote regions.
PREMIER HEALTH OF AMERICA IN
1114 Cure-Labelle Blvd., Suite 01
Blainville QUEBEC J7C 2M9 CA
CEO: Martin Legault
Employees: 20
Company Website: https://www.premierhealthgroup.ca/
Phone: 18002319916
The current stock price of PHA.CA is 0.18 CAD. The price increased by 2.86% in the last trading session.
The exchange symbol of PREMIER HEALTH OF AMERICA IN is PHA and it is listed on the TSX Venture Exchange exchange.
PHA.CA stock is listed on the TSX Venture Exchange exchange.
9 analysts have analysed PHA.CA and the average price target is 0.51 CAD. This implies a price increase of 183.33% is expected in the next year compared to the current price of 0.18. Check the PREMIER HEALTH OF AMERICA IN stock analysts ratings, price target forecast and up-and down grades for more detailed information.
PREMIER HEALTH OF AMERICA IN (PHA.CA) has a market capitalization of 9.99M CAD. This makes PHA.CA a Nano Cap stock.
PREMIER HEALTH OF AMERICA IN (PHA.CA) currently has 20 employees.
PREMIER HEALTH OF AMERICA IN (PHA.CA) has a support level at 0.17 and a resistance level at 0.19. Check the full technical report for a detailed analysis of PHA.CA support and resistance levels.
The Revenue of PREMIER HEALTH OF AMERICA IN (PHA.CA) is expected to decline by -8.95% in the next year. Check the estimates tab for more information on the PHA.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PHA.CA does not pay a dividend.
PREMIER HEALTH OF AMERICA IN (PHA.CA) will report earnings on 2025-05-21.
PREMIER HEALTH OF AMERICA IN (PHA.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.22).
ChartMill assigns a technical rating of 3 / 10 to PHA.CA. When comparing the yearly performance of all stocks, PHA.CA is a bad performer in the overall market: 89.1% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to PHA.CA. Both the profitability and financial health of PHA.CA have multiple concerns.
Over the last trailing twelve months PHA.CA reported a non-GAAP Earnings per Share(EPS) of -0.22. The EPS decreased by -632.19% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -16.94% | ||
ROE | -306.33% | ||
Debt/Equity | 0.84 |
ChartMill assigns a Buy % Consensus number of 84% to PHA.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 88.14% and a revenue growth -8.95% for PHA.CA